impaired left ventricular function [4] [5] [6] [7] . Troponin I reached peak values and confirmed myocardial necro sis when hHGF levels were already at a normal level [4] . Now, the very high hHGF values were ob served in patients admitted within the first 2 h of STEMI presentation (patients 5 and 6) ( Figure 1 , Table I ). In this aspect, the observed changes in hHGF concentrations in the early stage of myocardial infarction are a great advantage of this diagnostic method.
The time from the onset of ACS symptoms to treatment, effectiveness of reperfusion therapy measured as grade of flow in the infarct-related artery, and medical therapy applied during PPCI influence the levels of biomarkers [5, 8] . We supposed that in our study hHGF re-elevation was connected with acute complications of ACS. Due to the small number of patients we cannot definitely prove this relationship. We hope that subsequent research will confirm our preliminary observations. In conclusion, we found that: (1) in all our patients the highest hHGF values were observed at admission due to symptoms of acute coronary syndrome, (2) hHGF concentrations were reduced to normal values very quickly (within 5 h from the first measurement), (3) severe complications in the acute stage of STEMI most likely resulted in an additional increase in hHGF levels.
Acknowledgments
The study was supported as a statute project of the Institute of Cardiology (Warsaw, Poland, study number 2.32/II/06). The study was registered at ClinicalTrials.gov -registration number NCT 00844987. All authors declare that there have existed no conflicts of interest directly relevant to the content of the study. 
ACS -acute coronary syndrome, MI -myocardial infarction, STEMI -ST-segment elevation myocardial infarction, NSTEMI -non-ST-segment elevation myocardial infarction, cTnI -cardiac troponin I with diagnostic cut-point 0.1 ng/ml, PPCI -primary percutaneous coronary intervention, CRX -circumflex coronary artery, LAD -left descending coronary artery, CA -cardiac arrest, VF -ventricular fibrillation, EF -ejection fraction measured by echocardiography

